Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheung, M. M.
Right arrow Articles by Ngan, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, M. M.
Right arrow Articles by Ngan, R. K.

Journal of Clinical Oncology, Vol 16, 70-77, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

MM Cheung, JK Chan, WH Lau, W Foo, PT Chan, CS Ng and RK Ngan
Department of Radiotherapy and Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong. mcc@netvigator.com

PURPOSE: To study the clinical features and outcome for primary non- Hodgkin's lymphomas of the nose/nasopharynx (NNP-NHLs) according to immunophenotype. PATIENTS AND METHODS: One hundred thirteen Chinese patients with primary NNP-NHLs that belonged to the categories E, F, G, or H according to the Working Formulation (WF), with full immunophenotypic data and complete clinical follow-up data, were analyzed in this retrospective study. RESULTS: Ninety (79.6%) patients had localized (stage I or II) disease, while 23 (20.4%) had stage III or IV disease. The lymphomas in 51 (45.1%), 24 (21.3%), and 38 (33.6%) patients showed natural killer (NK)/T- (CD56-positive), T-cell, and B- cell immunophenotype, respectively. Seventy-three patients (65.8%) achieved a complete remission, of whom 34 (46.6%) subsequently relapsed. The median follow-up time for those alive was 88 months. The 5-year actuarial disease-free and overall survival rates were 34.4% and 37.9%, respectively. Multivariate analysis showed that only stage and immunophenotype were significant for survival. NK/T lymphomas were distinctive among the three immunophenotypes in the following aspects: the highest male-to-female ratio, more frequent involvement of the nasal cavity alone, higher risk of dissemination to the skin, more frequent development of hemophagocytic syndrome, and the worst prognosis (overall median survival, 12.5 months). CONCLUSION: The three immunophenotypes studied are shown to exhibit different clinical patterns. Since the NK/T phenotype carries the worst prognosis, patients who present with NNP-NHL should have their tumors analyzed for CD56 expression.


This article has been cited by other articles:


Home page
 Vet PatholHome page
A. K. Marr-Belvin, A. K. Carville, M. A. Fahey, K. Boisvert, S. A. Klumpp, M. Ohashi, F. Wang, S. P. O'Neil, and S. V. Westmoreland
Rhesus Lymphocryptovirus Type 1-associated B-cell Nasal Lymphoma in SIV-infected Rhesus Macaques
Vet. Pathol., November 1, 2008; 45(6): 914 - 921.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-X. Li, H. Fang, Q.-F. Liu, J. Lu, S.-N. Qi, H. Wang, J. Jin, W.-H. Wang, Y.-P. Liu, Y.-W. Song, et al.
Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
Blood, October 15, 2008; 112(8): 3057 - 3064.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B.-S. Kim, D.-W. Kim, S.-A. Im, C. W. Kim, T.-Y. Kim, S.-S. Yoon, D. S. Heo, Y.-J. Bang, S. Park, B. K. Kim, et al.
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
Ann. Onc., August 5, 2008; (2008) mdn551v1.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
T. M. Kim, S. -Y. Lee, Y. K. Jeon, B. -Y. Ryoo, G. J. Cho, Y. S. Hong, H. J. Kim, S.-Y. Kim, C. S. Kim, S. Kim, et al.
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
Ann. Onc., August 1, 2008; 19(8): 1477 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Lee, C. Suh, J. Huh, H. J. Jun, K. Kim, C. Jung, K. Park, Y. H. Park, Y. H. Ko, and W. S. Kim
Effect of Positive Bone Marrow EBV In situ Hybridization in Staging and Survival of Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal-Type
Clin. Cancer Res., June 1, 2007; 13(11): 3250 - 3254.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Bahl, S. Laskar, and M. A. Muckaden
Radiotherapy Alone for Nasal Natural-Killer/T-Cell Lymphoma
J. Clin. Oncol., June 10, 2006; 24(17): 2684 - 2685.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
J.W. Choi, S.S. Kim, E.Y. Kim, and M. Heran
Peripheral T-Cell Lymphoma in the Neck: CT Findings of Lymph Node Involvement.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1079 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. A. Rizvi, A. M. Evens, M. S. Tallman, B. P. Nelson, and S. T. Rosen
T-cell non-Hodgkin lymphoma
Blood, February 15, 2006; 107(4): 1255 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Lee, C. Suh, Y. H. Park, Y. H. Ko, S. M. Bang, J. H. Lee, D. H. Lee, J. Huh, S. Y. Oh, H.-C. Kwon, et al.
Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study
J. Clin. Oncol., February 1, 2006; 24(4): 612 - 618.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Y.-X. Li, B. Yao, J. Jin, W.-H. Wang, Y.-P. Liu, Y.-W. Song, S.-L. Wang, X.-F. Liu, L.-Q. Zhou, X.-H. He, et al.
Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma
J. Clin. Oncol., January 1, 2006; 24(1): 181 - 189.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. M. Kim, Y. H. Park, S.-Y. Lee, J.-H. Kim, D.-W. Kim, S.-A. Im, T.-Y. Kim, C. W. Kim, D. S. Heo, Y.-J. Bang, et al.
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type
Blood, December 1, 2005; 106(12): 3785 - 3790.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, et al.
WHO-EORTC classification for cutaneous lymphomas
Blood, May 15, 2005; 105(10): 3768 - 3785.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Kim, E. K. Chie, C. W. Kim, I. H. Kim, and C. I. Park
Treatment Outcome of Angiocentric T-cell and NK/T-cell Lymphoma, Nasal Type: Radiotherapy Versus Chemoradiotherapy
Jpn. J. Clin. Oncol., January 1, 2005; 35(1): 1 - 5.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
K. J. Savage
Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types)
Hematology, January 1, 2005; 2005(1): 267 - 277.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
T.-t. Kuo, L.-Y. Shih, and N.-M. Tsang
Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities
International Journal of Surgical Pathology, October 1, 2004; 12(4): 375 - 387.
[Abstract] [PDF]

Home page
 BloodHome page
W.-Y. Au, A. Pang, C. Choy, C.-S. Chim, and Y.-L. Kwong
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients
Blood, July 1, 2004; 104(1): 243 - 249.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. G. Rose and N. Berliner
T-Cell Large Granular Lymphocyte Leukemia and Related Disorders
Oncologist, June 1, 2004; 9(3): 247 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A D King, K I Lei, and A T Ahuja
MRI of neck nodes in non-Hodgkin's lymphoma of the head and neck
Br. J. Radiol., February 1, 2004; 77(914): 111 - 115.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C.-S. Chim, S.-Y. Ma, W.-Y. Au, C. Choy, A. K. W. Lie, R. Liang, C.-C. Yau, and Y.-L. Kwong
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
Blood, January 1, 2004; 103(1): 216 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
W. Y. Au, A. K. W. Lie, R. Liang, Y.-L. Kwong, C.-C. Yau, M. M. C. Cheung, K.-C. Ngan, W.-H. Lau, K.-H. Wong, H.-Y. Yiu, et al.
Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value
Ann. Onc., November 1, 2003; 14(11): 1673 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
H. J. Lee, J.-G. Im, J. M. Goo, K. W. Kim, B. I. Choi, K. H. Chang, J. K. Han, and M. H. Han
Peripheral T-Cell Lymphoma: Spectrum of Imaging Findings with Clinical and Pathologic Features
RadioGraphics, January 1, 2003; 23(1): 7 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
F. Farhat, M. Djokic, and R. M. Naclerio
Pathology Quiz Case 2
Arch Otolaryngol Head Neck Surg, November 1, 2002; 128(11): 1327 - 1329.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. I. K. Lei, L. Y. S. Chan, W.-Y. Chan, P. J. Johnson, and Y. M. D. Lo
Diagnostic and Prognostic Implications of Circulating Cell-free Epstein-Barr Virus DNA in Natural Killer/T-Cell Lymphoma
Clin. Cancer Res., January 1, 2002; 8(1): 29 - 34.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. L. Ping Siu, J. K. Cheung Chan, K.-F. Wong, and Y.-L. Kwong
Specific Patterns of Gene Methylation in Natural Killer Cell Lymphomas : p73 Is Consistently Involved
Am. J. Pathol., January 1, 2002; 160(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Quintanilla-Martinez, M. Kremer, G. Keller, M. Nathrath, A. Gamboa-Dominguez, A. Meneses, L. Luna-Contreras, A. Cabras, H. Hoefler, A. Mohar, et al.
p53 Mutations in Nasal Natural Killer/T-Cell Lymphoma from Mexico : Association with Large Cell Morphology and Advanced Disease
Am. J. Pathol., December 1, 2001; 159(6): 2095 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Nagata, A. Konno, N. Kimura, Y. Zhang, M. Kimura, A. Demachi, T. Sekine, K. Yamamoto, and N. Shimizu
Characterization of novel natural killer (NK)-cell and {gamma}{delta} T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus
Blood, February 1, 2001; 97(3): 708 - 713.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr.
T Cell and NK Cell Lymphoproliferative Disorders
Hematology, January 1, 2001; 2001(1): 259 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. L. P. Siu, V. Chan, J. K. C. Chan, K.-F. Wong, R. Liang, and Y.-L. Kwong
Consistent Patterns of Allelic Loss in Natural Killer Cell Lymphoma
Am. J. Pathol., December 1, 2000; 157(6): 1803 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
S. S. Khariwala, D. A. Litman, S. J. McQuone, J. L. Hess, and E. R. Thaler
Quiz Case 2
Arch Otolaryngol Head Neck Surg, November 1, 2000; 126(11): 1391 - 1393.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
G. C. Ooi, C. S. Chim, R. Liang, K. W. T. Tsang, and Y. L. Kwong
Nasal T-Cell/Natural Killer Cell Lymphoma: CT and MR Imaging Features of a New Clinicopathologic Entity
Am. J. Roentgenol., April 1, 2000; 174(4): 1141 - 1145.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. D. King, K. I. K. Lei, A. T. Ahuja, W. W. M. Lam, and C. Metreweli
MR Imaging of Nasal T-Cell/Natural Killer Cell Lymphoma
Am. J. Roentgenol., January 1, 2000; 174(1): 209 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. L. P. Siu, K.-F. Wong, J. K. C. Chan, and Y.-L. Kwong
Comparative Genomic Hybridization Analysis of Natural Killer Cell Lymphoma/Leukemia : Recognition of Consistent Patterns of Genetic Alterations
Am. J. Pathol., November 1, 1999; 155(5): 1419 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. S. Chim, G. C. Ooi, T. W.H. Shek, R. Liang, and Y. L. Kwong
Lethal Midline Granuloma Revisited: Nasal T/Natural-Killer Cell Lymphoma
J. Clin. Oncol., April 1, 1999; 17(4): 1322 - 1322.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online